Moorin Jay Insider Trades

Insider Trading History

Track insider trading activity for Moorin Jay. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Agile Therapeutics
Agile Therapeutics AGRX
10% owner
Holding Value $7.64M 5,062,363 shares
Last Trade
Jan 27, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$250B 393,700 shares
$636,000.00
$1.51
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $7.88k 15,000 shares
Last Trade
Jan 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.29M 15,000 shares
$86.15
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $5.25k 10,000 shares
Last Trade
Apr 21, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$593k 10,000 shares
$59.31
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $2.63k 5,000 shares
Last Trade
Mar 13, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$230k 5,000 shares
$46.09
$0.52
Agile Therapeutics
Agile Therapeutics AGRX
10% owner
Holding Value $7.05M 4,668,663 shares
Last Trade
Jan 23, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$612B 811,966 shares
$754,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
10% owner
Holding Value $5.82M 3,856,697 shares
Last Trade
May 29, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$666B 1,120,833 shares
$594,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
10% owner
Holding Value $4.13M 2,735,864 shares
Last Trade
May 29, 2014 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.62T 2,733,141 shares
$594,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
10% owner
Holding Value $0 0 shares
Last Trade
May 29, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.09T 1,839,262 shares
$594,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
10% owner
Holding Value $0 0 shares
Last Trade
May 29, 2014 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$84.2B 141,825 shares
$594,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
10% owner
Holding Value $4.11k 2,723 shares
Last Trade
May 22, 2014 Sale
No data
No data
$1.51
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $2.46k 4,680 shares
Last Trade
Apr 08, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.3k 4,680 shares
$12.67
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $0 0 shares
Last Trade
Feb 18, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$39.2M 3,028,533 shares
$12.94
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $0 0 shares
Last Trade
Feb 18, 2014 Sale (In The Money)Reported as In The Money on SEC Form 4.
$20.9k 1,614 shares
$12.94
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $2.5M 4,770,828 shares
Last Trade
Feb 18, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.31M 333,333 shares
$12.94
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $2.33M 4,437,495 shares
Last Trade
Feb 18, 2014 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$259k 22,194 shares
$11.67
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $2.32M 4,415,658 shares
Last Trade
Feb 18, 2014 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$57.6M 4,448,591 shares
$12.94
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $0 0 shares
Last Trade
Feb 11, 2014 Sale
No data
No data
$0.52
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $20.5k 39,001 shares
Last Trade
Feb 11, 2014 Sale
No data
No data
$0.52
GraniteShares ETF Trust - GraniteShares 2x Long NVDA Daily ETF
GraniteShares ETF Trust - GraniteShares 2x Long NVDA Daily ETF NVDL
10% owner
Holding Value $1.87B 17,120,360 shares
Last Trade
Apr 04, 2011 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$109.45
GraniteShares ETF Trust - GraniteShares 2x Long NVDA Daily ETF
GraniteShares ETF Trust - GraniteShares 2x Long NVDA Daily ETF NVDL
10% owner
Holding Value $0 0 shares
Last Trade
Nov 10, 2010 Sale (In The Money)Reported as In The Money on SEC Form 4.
No data
No data
$109.45

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up